Inhibitors of bromodomain-containing protein 4 (BRD4)

US11117865B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11117865-B2
Application numberUS-201916442526-A
CountryUS
Kind codeB2
Filing dateJun 16, 2019
Priority dateDec 16, 2016
Publication dateSep 14, 2021
Grant dateSep 14, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Certain embodiments are directed to small molecule selective inhibitors of the BRD4 bromodomain. Compounds described herein can be used to modulate the bronchiolar NFkB-BRD4 axis, which plays a role in acute neutrophilic response to viral molecular patterns. Compounds described herein can be developed as preventive and therapeutic agents for various human diseases and conditions.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound, or a pharmaceutically acceptable salt thereof, having Formula III: wherein: R 11 , R 12 , and R 13 are independently H, —OH, halogen, alkoxy, —NH 2 , —CF 3 , —(CO)R 17 where R 17 is alkyl, alkoxy, amino, or alkylamino; R 14 is a C1-4 alkyl substituted with one or more of OH, alkoxy, amino, alkylamino, or an unsubstituted 5-6 membered heterocycle with 1-3 heteroatoms. 2. The compound of claim 1 , wherein the compound is selected from compound having a structure of 3. The compound of claim 2 , wherein the compound has a structure of; 4. A compound, or a pharmaceutically acceptable salt thereof, having the Formula IIIa: wherein: R 11 , R 12 , and R 13 are independently H, —OH, halogen, alkoxy, —NH 2 , —CF 3 , —(CO)R 17 where R 17 is alkyl, alkoxy, amino, or alkylamino; R 15 is H, —OH, alkyl, or NH 2 ; p is 0-4; R 16 is H, —OH, alkyl, alkoxy; or —NR 18 R 19 where R 18 and R 19 are independently H, alkyl; or R 18 and R 19 are optionally joined to form a 3-6 membered substituted or unsubstituted heterocycle having 1-3 heteroatoms; wherein at least one of R 11 , R 12 , or R 13 is —OH, halogen, alkoxy, —NH 2 , —CF 3 , —(CO)R 17 when R 15 is H, and R 16 is H or alkyl.

Assignees

Inventors

Classifications

  • containing three or more hetero rings · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms · CPC title

  • linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11117865B2 cover?
Certain embodiments are directed to small molecule selective inhibitors of the BRD4 bromodomain. Compounds described herein can be used to modulate the bronchiolar NFkB-BRD4 axis, which plays a role in acute neutrophilic response to viral molecular patterns. Compounds described herein can be developed as preventive and therapeutic agents for various human diseases and conditions.
Who is the assignee on this patent?
Zhou Jia, Brasier Allan R, Tian Bing, and 4 more
What technology area does this patent fall under?
Primary CPC classification C07D215/38. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).